DOI: 10.36347/sjams.2016.v04i03.077

Pages: 1029-1031

Gingival overgrowth represents an over-exuberant response to a variety of local and systemic conditions. Certain anticonvulsants, immuno-suppressive drugs and a number of calcium channel blockers have been shown to produce similar gingival overgrowths in certain susceptible patients. Amlodipine, a third generation calcium channel blocker, used mostly as an anti-hypertensive drug has been shown to promote gingival overgrowth, although reported in very limited cases. A rare case of amlodipine-induced gingival overgrowth has been reported herein in a 55-year-old male patient. The treatment aspect included Phase-1 therapy, substitution of the drug, the surgical excision and the maintenance and supportive therapy resulting in excellent clinical outcome.